Ocugen, Inc. Total Assets

• Ocugen, Inc. showed a decrease of -47.2% in Total Assets from 2024 to 2025.
• This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
• XBRL data for this metric is available from 2014 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2015: $61.58 million | Q2 2015: $53.24 million | Q3 2015: $45.30 million | Q1 2016: $28.52 million | Q2 2016: $21.28 million | Q3 2016: $42.80 million | Q1 2017: $28.31 million | Q2 2017: $22.13 million | Q3 2017: $15.83 million | Q1 2018: $21.33 million | Q2 2018: $15.15 million | Q3 2018: $10.88 million | Q1 2019: $14.84 million | Q2 2019: $3.20 million | Q3 2019: $23.62 million | Q1 2020: $12.31 million | Q2 2020: $23.76 million | Q3 2020: $20.54 million | Q1 2021: $53.85 million | Q2 2021: $124.25 million | Q3 2021: $116.31 million | Q1 2024: $51.79 million | Q2 2024: $40.54 million | Q3 2024: $61.94 million | Q1 2025: $64.46 million | Q2 2025: $53.59 million | Q3 2025: $57.60 million.
• Over the full 18 years of available data (2014 to 2025), Ocugen, Inc.'s Total Assets has declined by 33.6%.
• Historical annual values: Fiscal year 2025: $43.52 million | Fiscal year 2024: $82.44 million | Fiscal year 2023: $64.55 million | Fiscal year 2023: $74.69 million | Fiscal year 2023: $88.98 million | Fiscal year 2023: $96.30 million | Fiscal year 2022: $108.63 million | Fiscal year 2022: $116.24 million | Fiscal year 2022: $130.09 million | Fiscal year 2022: $141.73 million | Fiscal year 2021: $105.76 million | Fiscal year 2020: $27.38 million | Fiscal year 2019: $16.81 million | Fiscal year 2018: $2.45 million | Fiscal year 2017: $11.04 million | Fiscal year 2016: $36.08 million | Fiscal year 2015: $36.79 million | Fiscal year 2014: $65.50 million.
• Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: August 4, 2026